VJOncology Podcast
By VJOncology
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by VJOncology
Category: Medicine
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 1
Reviews: 0
Episodes: 222
Description
The Video Journal of Oncology (VJOncology) podcast covers the latest oncology news from international experts across a view variety of solid tumors. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjoncology.com
| Episode | Date |
|---|---|
|
Gastrointestinal cancer updates at ASCO 2026: RASolute 302, EMERALD-3, and more
|
Jun 12, 2026 |
|
Highlights from ASCO 2026
|
Jun 08, 2026 |
|
iwCAR-T 2026: CARs targeting cell surface proteins
|
May 15, 2026 |
|
Bladder Cancer Awareness Month: subtypes, diagnostics & breakthroughs
|
May 08, 2026 |
|
Oncology highlights from AACR 2026
|
May 01, 2026 |
|
Beyond EGFR: navigating molecular targets and emerging therapies in advanced NSCLC
|
Apr 30, 2026 |
|
Head and neck cancer awareness month: key trials and evolving treatment strategies
|
Apr 17, 2026 |
|
Lung cancer highlights from the 24th BTOG annual conference
|
Mar 27, 2026 |
|
Immuno-oncology updates from 12th Immunotherapy of Cancer Conference
|
Mar 20, 2026 |
|
Top updates from ASCO GU 2026: latest trials in prostate, kidney, and bladder cancer
|
Mar 06, 2026 |
|
Esophageal cancer awareness month: from multidisciplinary dialogue to clinical impact
|
Feb 20, 2026 |
|
ctDNA-guided surveillance and treatment monitoring in breast cancer
|
Feb 13, 2026 |
|
What’s new in checkpoint inhibition? LAG-3/PD-1 bispecifics, ADC combos, and more
|
Feb 06, 2026 |
|
Cervical cancer awareness month: advances in prevention and treatment
|
Feb 05, 2026 |
|
Immunotherapy's expanding role in GI cancers: from 1L to adjuvant settings
|
Jan 26, 2026 |
|
From biology to breakthroughs: new frontiers in head and neck cancer immunotherapy
|
Jan 23, 2026 |
|
How is AI transforming oncology care in 2026? From evidence to clinical practice
|
Jan 09, 2026 |
|
Highlights from SABCS 2025
|
Dec 18, 2025 |
|
Updates in GU cancer at ESMO 2025: SunRISe-4, PSMAddition, and more
|
Dec 05, 2025 |
|
GI cancer highlights at ESMO 2025: FORTITUDE-101, STELLAR-303, and more
|
Nov 28, 2025 |
|
Lung cancer at ESMO 2025: new targets, biomarkers & the changing landscape
|
Nov 26, 2025 |
|
ESSO 44: the latest updates in surgical oncology
|
Nov 07, 2025 |
|
Breast Cancer Awareness Month - the evolving role of ADCs
|
Oct 31, 2025 |
|
Highlights from ESMO 2025
|
Oct 24, 2025 |
|
Liver cancer awareness month: evolving strategies in immunotherapy and targeted treatment
|
Oct 10, 2025 |
|
Challenges and opportunities in cerebrospinal fluid liquid biopsies in brain tumors
|
Oct 03, 2025 |
|
From cold tumors to hot targets: immunotherapy advances in sarcoma treatment
|
Sep 26, 2025 |
|
WCLC 2025 highlights: FLAURA2, HARMONi, and more
|
Sep 12, 2025 |
|
Precision medicine in head & neck cancer: the rise of ADCs and targeted agents
|
Sep 05, 2025 |
|
Therapeutic options beyond ADCs in HER+ breast cancer
|
Aug 29, 2025 |
|
AI in Oncology: From Detection to Treatment
|
Aug 22, 2025 |
|
GI cancer highlights from ASCO 2025 with J. Randolph Hecht, Jasmine Mitchell and Jingran Ji
|
Aug 15, 2025 |
|
Highlights in GU cancer at ASCO 2025
|
Aug 08, 2025 |
|
Evolving strategies in gynecologic cancer care
|
Aug 06, 2025 |
|
Sarcoma awareness month: advances in precision medicine
|
Jul 25, 2025 |
|
CAR-T and cellular therapy updates in brain tumors
|
Jul 18, 2025 |
|
Breakthrough advances from ESMO GI 2025
|
Jul 11, 2025 |
|
Lung cancer highlights from ASCO 2025 with Joao Victor Alessi and Alessandro Di Federico
|
Jul 03, 2025 |
|
Breast Cancer highlights from ASCO 2025 with Kevin Kalinsky and Komal Jhaveri
|
Jun 27, 2025 |
|
Gynecological cancer updates at ASCO 2025
|
Jun 20, 2025 |
|
Breakthrough advances from ASCO 2025
|
Jun 13, 2025 |
|
Expanding Cell Therapy - TILs, TCRs & CARs in Lung Cancer and Melanoma
|
May 16, 2025 |
|
VJOncoAlert Journal Club
|
Apr 25, 2025 |
|
Adjuvant Therapy for Hepatocellular Carcinoma
|
Apr 04, 2025 |
|
Prostate cancer awareness month: advances in liquid biopsies
|
Mar 28, 2025 |
|
BTOG 2025 highlights
|
Mar 21, 2025 |
|
Liquid biopsy in breast cancer
|
Mar 14, 2025 |
|
Prostate cancer awareness month: developments in radioligand therapy
|
Mar 07, 2025 |
|
Key updates at ASCO GU 2025: STAMPEDE, CheckMate 214, and more
|
Feb 21, 2025 |
|
Cellular therapies in solid tumors
|
Feb 14, 2025 |
|
Therapeutic options for PD1 refractory skin cancer
|
Jan 24, 2025 |
|
Unlocking the Potential of ctDNA in Colorectal Cancer Management
|
Jan 17, 2025 |
|
Breast Cancer Updates from SABCS 2024
|
Jan 10, 2025 |
|
Novel immune checkpoint targets beyond PD-1 and CTLA-4 in solid tumors
|
Dec 20, 2024 |
|
Antibody drug conjugates in gastrointestinal cancers
|
Nov 29, 2024 |
|
Novel therapeutics in PD-1 refractory melanoma
|
Nov 15, 2024 |
|
Climate Change and Other Environmental Factors on Lung Cancer Risk at WCLC 2024
|
Nov 08, 2024 |
|
GI updates from ESMO 2024
|
Nov 04, 2024 |
|
Updates in the management of refractory colorectal cancer
|
Oct 25, 2024 |
|
ESSO 43 Highlights
|
Oct 11, 2024 |
|
Highlights from ESMO 2024
|
Sep 20, 2024 |
|
Latest updates in managing brain metastases
|
Sep 11, 2024 |
|
Updates in immunotherapy for GU cancer
|
Aug 23, 2024 |
|
Advancements in precision medicine for colorectal cancer
|
Aug 09, 2024 |
|
iwCAR-T sessions: clinical advances in GI cancers
|
Aug 07, 2024 |
|
iwCAR-T sessions: cell therapies for melanoma and sarcomas
|
Jul 26, 2024 |
|
iwCAR-T sessions: Advances in breast and gynecological cancers
|
Jul 19, 2024 |
|
iwCAR-T sessions: CAR-T clinical advances in lung cancer
|
Jul 12, 2024 |
|
Highlights in colorectal cancer at ASCO and ESMO GI 2024
|
Jul 05, 2024 |
|
Skin Cancer Highlights at ASCO 2024
|
Jun 24, 2024 |
|
iwCAR-T sessions: Clinical Advances in Head and Neck Cancer and Brain Tumors
|
Jun 07, 2024 |
|
ELCC 2024 highlights
|
May 24, 2024 |
|
Key Updates from ESMO Breast 2024
|
May 17, 2024 |
|
Bladder Cancer Awareness Month Part II: Management of UC in the UK
|
May 10, 2024 |
|
Bladder Cancer Awareness Month Part I: The past, present, and future of ADCs
|
May 03, 2024 |
|
BTOG 2024 Highlights
|
Apr 26, 2024 |
|
Highlights from AACR 2024: KRYSTAL-1, FLAURA2, and EDGE
|
Apr 12, 2024 |
|
Updates in immunotherapy for head and neck cancer
|
Mar 28, 2024 |
|
Updates in immunotherapy for skin cancer
|
Mar 22, 2024 |
|
Highlights in colorectal cancer at ASCO GI 2024
|
Mar 08, 2024 |
|
Targeted therapies for lung cancer at TTLC 2024
|
Mar 01, 2024 |
|
Updates in invasive lobular carcinoma (ILC)
|
Feb 23, 2024 |
|
Esophageal and gastric cancer highlights from ASCO GI 2024
|
Feb 16, 2024 |
|
Key updates at ASCO GU 2024
|
Feb 09, 2024 |
|
Highlights in bladder and prostate cancer at PROCSA/BLADDR 2023
|
Feb 02, 2024 |
|
Key updates at ESMO Asia 2023
|
Jan 26, 2024 |
|
Breast Cancer Sessions: Highlights from SABCS 2023 with Sara Tolaney, Sarah Sammons & Paolo Tarantino
|
Jan 12, 2024 |
|
Updates in GI cancer at ESMO 2023
|
Jan 05, 2024 |
|
2023 updates in metastatic colorectal cancer genomic biomarkers
|
Dec 22, 2023 |
|
Highlights in cancer nursing at UKONS 2023
|
Dec 01, 2023 |
|
Highlights in gynecologic cancer from ESMO 2023
|
Nov 24, 2023 |
|
Highlights in breast cancer from ESMO 2023
|
Nov 17, 2023 |
|
Highlights in lung cancer from ESMO 2023
|
Nov 10, 2023 |
|
Highlights in GU cancer at ESMO 2023
|
Nov 03, 2023 |
|
EGFR exon 20 insertions and how to manage patients in the UK
|
Oct 13, 2023 |
|
Updates in immunotherapy for brain tumors
|
Sep 15, 2023 |
|
Developments in radiotherapy for GI cancer
|
Sep 08, 2023 |
|
Latest advances in early-stage breast cancer
|
Aug 25, 2023 |
|
Applications of AI in Oncology
|
Aug 18, 2023 |
|
Targeted radionuclide therapy in prostate cancer
|
Aug 11, 2023 |
|
Latest updates in mesothelioma
|
Aug 04, 2023 |
|
iwCAR-T Session V: Advances in head & neck and CNS cancers
|
Jul 28, 2023 |
|
Highlights in GI cancer from ESMO WCGIC 2023
|
Jul 21, 2023 |
|
Updates in immunotherapy for head and neck cancer
|
Jul 14, 2023 |
|
iwCAR-T session VI: Advances in GI cancers
|
Jul 07, 2023 |
|
Highlights in bladder cancer at ASCO 2023: NORSE, RAGNAR, and THOR
|
Jun 30, 2023 |
|
ASCO 2023 Highlights: THOR, INDIGO and ADAURA
|
Jun 23, 2023 |
|
iwCAR-T Session III: CAR-T clinical advances in lung cancer
|
Jun 16, 2023 |
|
iwCAR-T Session II: Cell therapies in GU cancers
|
May 25, 2023 |
|
iwCAR-T Session I: Emerging CARs and future challenges in solid tumors
|
May 19, 2023 |
|
Highlights at AACR 2023: mRNA vaccines in melanoma and novel RAF inhibitors
|
May 09, 2023 |
|
Liquid biopsy in lung cancer: precision medicine and MRD
|
Apr 28, 2023 |
|
St. Gallen highlights: controversies in the axilla
|
Apr 14, 2023 |
|
Radiotherapy Highlights from ASCO GU 2023 with Sophia Kamran, Himanshu Nagar, and Neha Vapiwala
|
Apr 06, 2023 |
|
Chemotherapy, post-adjuvant therapy, and clinical trial ethics at St Gallen BCC 2023
|
Mar 31, 2023 |
|
Key Trials from ASCO GU 2023 with Scott Tagawa, Karie Runcie, and Tanya Dorff
|
Mar 24, 2023 |
|
Biomarkers, patient selection, and immunotherapy at ESMO Gynae 2023
|
Mar 17, 2023 |
|
Hot topics in renal cell carcinoma and rare tumors
|
Mar 10, 2023 |
|
Key data and hot topics in prostate cancer at ASCO GU 2023
|
Mar 03, 2023 |
|
Hot Topics in Bladder Cancer at ASCO GU 2023
|
Feb 24, 2023 |
|
Approaches to NSCLC With or Without Targetable Mutations
|
Feb 17, 2023 |
|
CAR-T in solid tumors: advances and challenges in targeting CLDN18.2, HER2 and STEAP 1
|
Feb 10, 2023 |
|
ASCO GI 2023: Bile duct cancer updates with Ghassan Abou-Alfa
|
Feb 03, 2023 |
|
Breast Cancer Sessions: Highlights from SABCS 2022 with Sara Tolaney, Paolo Tarantino & Sarah Sammons
|
Jan 27, 2023 |
|
Updates in cervical cancer
|
Jan 20, 2023 |
|
Resistance to immune checkpoint inhibitors in NSCLC
|
Jan 13, 2023 |
|
Impact of race on breast cancer outcomes
|
Jan 06, 2023 |
|
Immunotherapy updates in GI cancer
|
Dec 23, 2022 |
|
Updates from ESMO Asia 2022
|
Dec 16, 2022 |
|
Updates in EGFR-mutant NSCLC
|
Dec 02, 2022 |
|
UKONS 2022: cancer care in the digital age
|
Nov 25, 2022 |
|
Updates in immunotherapy from SITC 2022
|
Nov 18, 2022 |
|
Advances in radiotherapy from ASTRO 2022
|
Nov 16, 2022 |
|
Immunotherapy Updates in Head & Neck Cancer
|
Nov 04, 2022 |
|
Evolving role of ctDNA in breast cancer
|
Oct 28, 2022 |
|
Updates in Immuno-Oncology from ITOC 2022
|
Oct 24, 2022 |
|
ESMO 2022: Updates in Sarcoma
|
Oct 14, 2022 |
|
GI Cancer Sessions: ESMO Highlights with Geoffrey Ku and Sam Klempner
|
Oct 12, 2022 |
|
Breast Cancer Sessions: Highlights from ESMO 2022 with Elisa Agostinetto & Evandro de Azambuja
|
Oct 10, 2022 |
|
ESMO 2022: Updates in Colorectal Cancer
|
Sep 30, 2022 |
|
ESMO 2022: Updates in Breast Cancer
|
Sep 26, 2022 |
|
ESMO 2022 Daily Round-Ups: Day 4
|
Sep 12, 2022 |
|
ESMO 2022 Daily Round-Ups: Day 3
|
Sep 12, 2022 |
|
ESMO 2022 Daily Round-Ups: Day 2
|
Sep 11, 2022 |
|
The Lung Cancer Sessions: Updates from WCLC 2022
|
Sep 02, 2022 |
|
TILs, Cancer Vaccines & the Future of Cellular Therapies in Melanoma with Allison Betof Warner
|
Aug 26, 2022 |
|
Updates in lung cancer from WCLC 2022
|
Aug 19, 2022 |
|
Updates in checkpoint inhibitors for kidney cancer
|
Aug 12, 2022 |
|
iwCART Sessions: CAR-T clinical advances in breast and ovarian cancer
|
Aug 05, 2022 |
|
Clinical Applications of ctDNA in Oncology
|
Jul 29, 2022 |
|
iwCART Sessions: CAR-T clinical advances in lung cancer
|
Jul 22, 2022 |
|
ASCO 2022: Updates in Gastrointestinal Cancer
|
Jul 15, 2022 |
|
ASCO 2022: Updates in Genitourinary Cancer
|
Jul 08, 2022 |
|
ASCO 2022: Updates in Breast Cancer
|
Jul 01, 2022 |
|
ASCO 2022: Updates in Lung Cancer
|
Jun 24, 2022 |
|
iwCAR-T Sessions: emerging CARs & challenges in solid tumors
|
Jun 17, 2022 |
|
ASCO 2022 Daily Round-Ups: Day 3
|
Jun 05, 2022 |
|
ASCO 2022 Daily Round-Ups: Day 2
|
Jun 04, 2022 |
|
ASCO 2022 Daily Round-Ups - Day 1
|
Jun 04, 2022 |
|
Updates in radiation oncology from ESTRO 2022
|
May 27, 2022 |
|
Breast Cancer Sessions: Treatment de-escalation in TNBC
|
May 20, 2022 |
|
Trial updates from ESMO Breast Cancer 2022: TUXEDO-1, monarchE, KEYNOTE-355
|
May 16, 2022 |
|
Updates in GI cancers from AACR 2022
|
May 06, 2022 |
|
Expanding use of artificial intelligence (AI) in oncology
|
Apr 29, 2022 |
|
The evolving role of nurses amidst global pandemic: perspectives, and highlights from cancer nursing leaders
|
Apr 22, 2022 |
|
The GU Cancer Sessions: Prostate & kidney cancer highlights from ASCO GU 2022
|
Apr 11, 2022 |
|
Lung Cancer Screening: Current state and future directions
|
Apr 04, 2022 |
|
Novel treatment approaches in HR+/HER2- breast cancer
|
Mar 25, 2022 |
|
New treatment approaches for advanced or metastatic urothelial carcinoma
|
Mar 18, 2022 |
|
The Breast Cancer Sessions: Highlights from SABCS 2021
|
Mar 11, 2022 |
|
The GI Cancer Sessions: Highlights from ASCO GI 2022
|
Mar 04, 2022 |
|
Prostate Cancer Highlights from ASCO GU 2022
|
Feb 25, 2022 |
|
Updates on HER2-positive breast cancer
|
Feb 18, 2022 |
|
BTOG 2022: Highlights in lung cancer
|
Feb 11, 2022 |
|
The multidisciplinary use of ctDNA in gastrointestinal cancers
|
Feb 02, 2022 |
|
SITC 2021: Updates on the use of cellular therapy in solid tumors
|
Jan 19, 2022 |
|
Breast Cancer Sessions: Highlights from SABCS 2021 with Lisa Carey & Aleix Prat
|
Jan 14, 2022 |
|
Immunotherapy updates from SABCS 2021 with Heather McArthur & Kevin Kalinsky
|
Jan 04, 2022 |
|
The Lung Cancer Sessions: Advances in EGFR-mutated NSCLC
|
Nov 25, 2021 |
|
ISLB 2021: Current standards and future directions for liquid biopsy
|
Nov 12, 2021 |
|
Prostate Cancer Highlights from ESMO 2021 from Robert Jones
|
Oct 28, 2021 |
|
The GU Cancer Sessions: Bladder Highlights from ESMO 2021
|
Oct 19, 2021 |
|
The Lung Cancer Sessions: Highlights from ASCO 2021
|
Sep 22, 2021 |
|
The GI Cancer Sessions: Highlights from ASCO 2021
|
Sep 22, 2021 |
|
The Skin Cancer Sessions: Highlights from ASCO 2021
|
Sep 22, 2021 |
|
Key clinical trial data in urothelial carcinoma at ASCO 2021
|
Sep 10, 2021 |
|
Prostate Cancer Highlights from ASCO 2021 with Pedro Barata
|
Aug 23, 2021 |
|
The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO 2021
|
Aug 16, 2021 |
|
The Breast Cancer Sessions: Highlights from ASCO 2021
|
Aug 16, 2021 |
|
ASCO 2021: Immunotherapy updates in lung cancer
|
Aug 04, 2021 |
|
EAU 2021: updates in testicular cancer
|
Jul 28, 2021 |
|
Highlights from ESMO WCGIC 2021: VALENTINO, KEYNOTE-811 & BEACON-CRC
|
Jul 15, 2021 |
|
What's new? Treating breast cancer with brain metastases
|
Jul 14, 2021 |
|
Global breast cancer care
|
Jul 13, 2021 |
|
Latest developments in immunotherapy for patients with melanoma
|
Jul 01, 2021 |
|
ASCO 2021: PSMA-targeted radionuclide therapy for prostate cancer
|
Jun 25, 2021 |
|
ESMO Breast 2021: updates on immunotherapy
|
Jun 10, 2021 |
|
The Lung Cancer Sessions: Highlights from BTOG 2021
|
Jun 03, 2021 |
|
Sequencing HER2-targeting therapies in the metastatic breast cancer space
|
May 14, 2021 |
|
The GU Sessions: Prostate Cancer Highlights from ASCO GU 2021
|
May 13, 2021 |
|
Latest news in GU: CAR-T in RCC, updates from IMvigor130, & liquid biopsies in prostate cancer
|
May 13, 2021 |
|
The GU Cancer Sessions: Bladder and Kidney Highlights from ASCO GU 2021
|
May 13, 2021 |
|
BTOG 2021: KRAS targeting and oncogenically-driven lung cancer
|
May 12, 2021 |
|
The Breast Cancer Sessions: a focus on the St. Gallen Consensus
|
Apr 26, 2021 |
|
Predictive and prognostic biomarkers in breast cancer
|
Apr 07, 2021 |
|
The Lung Cancer Sessions: highlights from IASLC WCLC
|
Feb 18, 2021 |
|
The GI Cancer Sessions: Highlights from ASCO GI 2021
|
Feb 12, 2021 |
|
The Breast Cancer Sessions: Highlights from SABCS 2020
|
Jan 27, 2021 |
|
Highlights from SABCS 2020: immunotherapy, novel agents and trial updates
|
Jan 11, 2021 |
|
Key trial updates at SABCS 2020: monarchE, RxPONDER & ASCENT
|
Dec 15, 2020 |
|
Updates in non-small cell lung cancer from ESMO
|
Nov 03, 2020 |
|
Highlights from EADO 2020: novel therapies, neoadjuvant approaches & COVID-19
|
Oct 29, 2020 |
|
The Lung Cancer Sessions: learnings from the ESMO 2020 Science Weekend
|
Oct 14, 2020 |
|
The ONS/EONS Congress Roundtable Discussion with VJOncology and OncoAlert
|
Sep 10, 2020 |
|
Prioritizing patients for breast cancer surgery during COVID-19
|
Aug 03, 2020 |
|
Genotyping in lung cancer and multi-cancer detection
|
Jul 01, 2020 |
|
Molecular testing for lung cancer in the UK
|
May 13, 2020 |
|
Living with and beyond cancer: a patient’s quality of life is just as important as survival
|
Feb 04, 2019 |
|
Advancing immunotherapy for solid tumors
|
Nov 23, 2018 |
|
Updates in breast cancer: recent clinical trials, immunotherapy, challenges & future treatment outlook
|
Oct 11, 2018 |
|
Hot topics in oncology: precision medicine, biomarkers & immunotherapy
|
Sep 14, 2018 |
|
Bladder cancer: advances in the spotlight and what these mean for therapy
|
Aug 16, 2018 |